Literature DB >> 9199562

Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number.

P E McAndrew1, D W Parsons, L R Simard, C Rochette, P N Ray, J R Mendell, T W Prior, A H Burghes.   

Abstract

The survival motor neuron (SMN) transcript is encoded by two genes, SMNT and SMNC. The autosomal recessive proximal spinal muscular atrophy that maps to 5q12 is caused by mutations in the SMNT gene. The SMNT gene can be distinguished from the SMNC gene by base-pair changes in exons 7 and 8. SMNT exon 7 is not detected in approximately 95% of SMA cases due to either deletion or sequence-conversion events. Small mutations in SMNT now have been identified in some of the remaining nondeletion patients. However, there is no reliable quantitative assay for SMNT, to distinguish SMA compound heterozygotes from non-5q SMA-like cases (phenocopies) and to accurately determine carrier status. We have developed a quantitative PCR assay for the determination of SMNT and SMNC gene-copy number. This report demonstrates how risk estimates for the diagnosis and detection of SMA carriers can be modified by the accurate determination of SMNT copy number.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9199562      PMCID: PMC1716150          DOI: 10.1086/515465

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  44 in total

1.  Quantitative film detection of 3H and 14C in polyacrylamide gels by fluorography.

Authors:  R A Laskey; A D Mills
Journal:  Eur J Biochem       Date:  1975-08-15

2.  Linkage study of chronic childhood-onset spinal muscular atrophy (SMA): confirmation of close linkage to D5S39 in French Canadian families.

Authors:  L R Simard; M Vanasse; C Rochette; K Morgan; B Lemieux; S B Melançon; D Labuda
Journal:  Genomics       Date:  1992-09       Impact factor: 5.736

3.  Proximal spinal muscular atrophy (SMA) types II and III in the same sibship are not caused by different alleles at the SMA locus on 5q.

Authors:  B Müller; J Melki; P Burlet; F Clerget-Darpoux
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

4.  Gene for chronic proximal spinal muscular atrophies maps to chromosome 5q.

Authors:  J Melki; S Abdelhak; P Sheth; M F Bachelot; P Burlet; A Marcadet; J Aicardi; A Barois; J P Carriere; M Fardeau
Journal:  Nature       Date:  1990-04-19       Impact factor: 49.962

5.  Deletion and conversion in spinal muscular atrophy patients: is there a relationship to severity?

Authors:  C J DiDonato; S E Ingraham; J R Mendell; T W Prior; S Lenard; R T Moxley; J Florence; A H Burghes
Journal:  Ann Neurol       Date:  1997-02       Impact factor: 10.422

6.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

7.  Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3.

Authors:  L M Brzustowicz; T Lehner; L H Castilla; G K Penchaszadeh; K C Wilhelmsen; R Daniels; K E Davies; M Leppert; F Ziter; D Wood
Journal:  Nature       Date:  1990-04-05       Impact factor: 49.962

8.  A rapid and versatile method to synthesize internal standards for competitive PCR.

Authors:  F S Celi; M E Zenilman; A R Shuldiner
Journal:  Nucleic Acids Res       Date:  1993-02-25       Impact factor: 16.971

9.  Identification of mutations in exons 1 through 8 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Authors:  J Zielenski; D Bozon; B Kerem; D Markiewicz; P Durie; J M Rommens; L C Tsui
Journal:  Genomics       Date:  1991-05       Impact factor: 5.736

10.  Construction of a yeast artificial chromosome contig spanning the spinal muscular atrophy disease gene region.

Authors:  P W Kleyn; C H Wang; L L Lien; E Vitale; J Pan; B M Ross; A Grunn; D A Palmer; D Warburton; L M Brzustowicz
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

View more
  197 in total

1.  A method to compensate for different amplification efficiencies.

Authors:  S Ogino
Journal:  J Mol Diagn       Date:  2001-11       Impact factor: 5.568

2.  SMN dosage analysis and risk assessment for spinal muscular atrophy.

Authors:  Shuji Ogino; Robert B Wilson
Journal:  Am J Hum Genet       Date:  2002-06       Impact factor: 11.025

3.  Rapid detection of single nucleotide polymorphisms associated with spinal muscular atrophy by use of a reusable fibre-optic biosensor.

Authors:  James H Watterson; Sandeep Raha; Christopher C Kotoris; Christopher C Wust; Farhad Gharabaghi; Sarah C Jantzi; Nicole K Haynes; Nathalie H Gendron; Ulrich J Krull; Alex E Mackenzie; Paul A E Piunno
Journal:  Nucleic Acids Res       Date:  2004-01-23       Impact factor: 16.971

4.  Carrier incidence for spinal muscular atrophy in southern Chinese.

Authors:  Vivian Chan; Ben Yip; Irene Yam; Patrick Au; Che-Kit Lin; Virginia Wong; Tai-Kwong Chan
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

5.  Clinical utility gene card for: proximal spinal muscular atrophy.

Authors:  Sabine Rudnik-Schöneborn; Thomas Eggermann; Wolfram Kress; Henny H Lemmink; Jan-Maarten Cobben; Klaus Zerres
Journal:  Eur J Hum Genet       Date:  2012-04-18       Impact factor: 4.246

Review 6.  Spinal muscular atrophy: an update on therapeutic progress.

Authors:  Joonbae Seo; Matthew D Howell; Natalia N Singh; Ravindra N Singh
Journal:  Biochim Biophys Acta       Date:  2013-08-27

Review 7.  Applicability of histone deacetylase inhibition for the treatment of spinal muscular atrophy.

Authors:  Sebastian Lunke; Assam El-Osta
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

Review 8.  Mechanistic principles of antisense targets for the treatment of spinal muscular atrophy.

Authors:  Natalia N Singh; Brian M Lee; Christine J DiDonato; Ravindra N Singh
Journal:  Future Med Chem       Date:  2015-09-18       Impact factor: 3.808

9.  Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts.

Authors:  Leigh A Skordis; Matthew G Dunckley; Baigong Yue; Ian C Eperon; Francesco Muntoni
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-17       Impact factor: 11.205

10.  Diagnosis of spinal muscular atrophy in an SMN non-deletion patient using a quantitative PCR screen and mutation analysis.

Authors:  D W Parsons; P E McAndrew; P S Allinson; W D Parker; A H Burghes; T W Prior
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.